Sopharma Trading AD (XBUL:SFT) EPS (Diluted) : лв0.26 (TTM As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD EPS (Diluted)?

Sopharma Trading AD's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was лв0.13. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was лв0.26.

Sopharma Trading AD's EPS (Basic) for the three months ended in Sep. 2023 was лв0.13. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was лв0.27.

Sopharma Trading AD's EPS without NRI for the three months ended in Sep. 2023 was лв0.14. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was лв0.83.

During the past 12 months, Sopharma Trading AD's average EPS without NRIGrowth Rate was 16.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 42.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 16.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sopharma Trading AD's highest 3-Year average EPS without NRI Growth Rate was 42.10% per year. The lowest was -9.40% per year. And the median was 6.50% per year.

Sopharma Trading AD EPS (Diluted) Historical Data

The historical data trend for Sopharma Trading AD's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD EPS (Diluted) Chart

Sopharma Trading AD Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Diluted)

Get a 7-Day Free Trial

0.26

0.33

0.23

0.26

Sopharma Trading AD Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EPS (Diluted)	Get a 7-Day Free Trial															0.23	-0.43	0.32	0.24	0.13

Competitive Comparison of Sopharma Trading AD's EPS (Diluted)

For the Medical Distribution subindustry, Sopharma Trading AD's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma Trading AD's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's PE Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's PE Ratio falls into.

Sopharma Trading AD EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Sopharma Trading AD's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(9.08	-	0)	/	34.276
	=	0.26

Sopharma Trading AD's Diluted EPS for the quarter that ended in Sep. 2023 is calculated as

Diluted EPS (Q: Sep. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(4.477	-	0)	/	34.276
	=	0.13

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.26

Sopharma Trading AD (XBUL:SFT) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sopharma Trading AD EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma Trading AD (XBUL:SFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756

Website

http://www.sopharmatrading.bg

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines